Article citationsMore>>

ALNasser, M.N., Mellor, I.R. and Carter, W.G. (2022) A Preliminary Assessment of the Nutraceutical Potential of Acai Berry (Euterpe sp.) as a Potential Natural Treatment for Alzheimer’s Disease. Molecules, 27, Article 4891.
https://doi.org/10.3390/molecules27154891

has been cited by the following article:

• TITLE: Effects of a Cocktail Supplement of Ginkgo Biloba and Acai Extract on Cognitive Symptoms of Parkinson’s Disease

  AUTHORS: Yulia Dubrovensky

  KEYWORDS: Parkinson’s Disease (PD), Cognitive Function, Ginkgo Biloba, Acai Extract, Neurodegenerative Disorders, Natural Supplements, Cognitive Symptoms, Montreal Cognitive Assessment (MoCA), Dopaminergic Neurons, Antioxidants, Neuroprotection, Non-Motor Symptoms, Oxidative Stress, Polyphenols

  JOURNAL NAME: Advances in Parkinson's Disease, Vol.13 No.3, July 24, 2024

  ABSTRACT: Parkinson’s Disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, including cognitive impairment. Current treatments often involve synthetic drugs with significant side effects and potential for dependency. This study investigates the effects of a natural supplement combination of Ginkgo Biloba and Acai Extract on cognitive symptoms in a 77-year-old male with PD. The participant underwent a three-month supplementation regimen, with cognitive function assessed using the Montreal Cognitive Assessment (MoCA) test before and after the intervention. The results indicated an improvement in cognitive scores, suggesting that the combination of Ginkgo Biloba and Acai Extract may offer a promising alternative or adjunct to conventional PD treatments. This study highlights the potential of natural supplements in managing PD symptoms and calls for further research with larger sample sizes to confirm these findings. Human data was performed in accordance with the Declaration of Helsinki by the Roxbury District IRB Board (IRB Number: IRB00011767).